Contents

Current Vascular Pharmacology, Volume 10 - Number 6

Acknowledgement

, 10(6): i


DOI: 10.2174/157016112803520828




Editorial [Hot Topic Proceedings of the European Society of Cardiology Working Group on Peripheral Circulation Symposium "Cardiometabolic Risk and Vascular Disease – from Mechanisms to Treatment", Rome 3-5 November 2011 (Guest Editor: Francesco Cosentino Associate Guest Editors: Charalambos Vlachopoulos and Francesco Paneni)]

, 10(6): 677

Francesco Cosentino


DOI: 10.2174/157016112803520963




Dysglycemia and Abdominal Obesity

, 10(6): 678 - 679

Eberhard Standl


DOI: 10.2174/157016112803520936




Impact of Pre-Diabetes and Diabetes on Cardiovascular Outcomes

, 10(6): 680 - 683

Matteo Anselmino and Dario Sillano


DOI: 10.2174/157016112803520882




Mechanisms of Diabetic Dyslipidemia: Relevance for Atherogenesis

, 10(6): 684 - 686

Marcello Arca, Giovanni Pigna and Carla Favoccia


DOI: 10.2174/157016112803520864




Glucose and LDL Lowering: The Need for Intensive Therapy

, 10(6): 687 - 689

Stefano Del Prato


DOI: 10.2174/157016112803520792




Joint ESC/EASD Guidelines on Diabetes, where are we Now and where should we Go?

, 10(6): 690 - 692

Lars Ryden and Linda Mellbin


DOI: 10.2174/157016112803520891




SIRT1 – An Anti-Inflammatory Pathway at the Crossroads Between Metabolic Disease and Atherosclerosis

, 10(6): 693 - 696

Stephan Winnik, Sokrates Stein and Christian M. Matter


DOI: 10.2174/157016112803520756




p66 Shc as the Engine of Vascular Aging

, 10(6): 697 - 699

Francesco Paneni and Francesco Cosentino


DOI: 10.2174/157016112803520747




Genetic and Environmental Determinants of Early Vascular Ageing (EVA)

, 10(6): 700 - 701

Peter M. Nilsson


DOI: 10.2174/157016112803520981




Decreasing Arterial Aging by Controlling Blood Pressure Levels and Hypertension: A Step Forward

, 10(6): 702 - 704

Angelo Scuteri and Pedro Guimaraes Cunha


DOI: 10.2174/157016112803520954




Tetrahydrobiopterin: A Vascular Redox Target to Improve Endothelial Function

, 10(6): 705 - 708

Keith M. Channon


DOI: 10.2174/157016112803520819




Global Cardiovascular Risk Management in Primary Prevention

, 10(6): 709 - 711

Massimo Volpe and Giuliano Tocci


DOI: 10.2174/157016112803520729




The Utility of Emerging Biomarkers and Imaging for Assessment of Cardiovascular Risk

, 10(6): 712 - 714

Augusto Gallino


DOI: 10.2174/157016112803520873




Getting Patients to Target- Implementing the Guidelines

, 10(6): 715 - 717

Pantaleo Giannuzzi


DOI: 10.2174/157016112803520701




High Density Lipoprotein – Should we Raise it?

, 10(6): 718 - 719

Ulf Landmesser


DOI: 10.2174/157016112803520710




Therapeutic Targets to Raise HDL in Patients at Risk or with Coronary Artery Disease

, 10(6): 720 - 724

Thomas F. Luscher, Arnold von Eckardstein and Branko Simic


DOI: 10.2174/157016112803520972




Lessons from the REACH Registry in Europe

, 10(6): 725 - 727

Tabita M. Valentijn and Robert J. Stolker


DOI: 10.2174/157016112803520774




How to Identify Subjects with Poly-Vascular Disease?

, 10(6): 728 - 730

Charalambos Vlachopoulos, Dimitrios Terentes-Printzios and Christodoulos Stefanadis


DOI: 10.2174/157016112803520846




Management of Patients with Poly-Vascular Disease: Priorities for Revascularization Procedures

, 10(6): 731 - 733

Marco De Carlo and Leonardo Misuraca


DOI: 10.2174/157016112803520855




Treatment of Carotid Stenosis

, 10(6): 734 - 738

Emmanuel Touze


DOI: 10.2174/157016112803520800




Hypertension: Quo Vadis?

, 10(6): 739 - 742

Claudio Borghi


DOI: 10.2174/157016112803520927




Lipids and Non-Cardiac Vascular Disease: A Lecture Overview

, 10(6): 743 - 744

Dimitri P. Mikhailidis


DOI: 10.2174/157016112803520693




Editorial: [Aliskiren/Amlodipine Single-Pill Combinations: More Evidence in Favour of Combination Formulations for the Treatment of Hypertension]

, 10(6): 745 - 747

Niki Katsiki, Vasilios G. Athyros, Dimitri P. Mikhailidis and Asterios Karagiannis


DOI: 10.2174/157016112803520783




Antihypertensive Efficacy and Tolerability of Aliskiren/Amlodipine Single- Pill Combinations in Patients with an Inadequate Response to Aliskiren Monotherapy¥

, 10(6): 748 - 755

Nicola Glorioso, Mathew Thomas, Chiara Troffa, Giuseppe Argiolas, Samir Patel, Inyoung Baek and Jack Zhang


DOI: 10.2174/157016112803520765




Molecular Link between Intravascular Hemolysis and Vascular Occlusion in Sickle Cell Disease

, 10(6): 756 - 761

Zhou Zhou, Donald L. Yee and Prasenjit Guchhait


DOI: 10.2174/157016112803520738




Thrombotic Thrombocytopenic Purpura and Anti-Thrombotic Therapy Targeted to Von Willebrand Factor

, 10(6): 762 - 766

Zhou Zhou and Jing-Fei Dong


DOI: 10.2174/157016112803520837




Statins and Portal Hypertension: A New Pharmacological Challenge

, 10(6): 767 - 772

Gonzalo Ramirez, Jimmy Briceno and Armando Rojas


DOI: 10.2174/157016112803520918




Efficacy and Tolerability of Aliskiren/Amlodipine Single-Pill Combinations in Patients who did not Respond Fully to Amlodipine Monotherapy¥

, 10(6): 773 - 780

Dietrich Pfeiffer, Nicola Rennie, Cheraz C. Papst and Jack Zhang


DOI: 10.2174/157016112803520945




The Effects of Incretins on Energy Homeostasis: Physiology and Implications for the Treatment of Type 2 Diabetes Mellitus and Obesity

, 10(6): 781 - 791

Spyridon Karras, Dimitrios G. Goulis, Gesthimani Mintziori, Niki Katsiki and Themistoklis Tzotzas


DOI: 10.2174/157016112803520909




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science